KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $7.1 million.

  • Idexx Laboratories' Change in Account Payables rose 59044.67% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $762000.0, marking a year-over-year decrease of 9112.82%. This contributed to the annual value of $8.1 million for FY2024, which is 155170.56% up from last year.
  • Per Idexx Laboratories' latest filing, its Change in Account Payables stood at $7.1 million for Q3 2025, which was up 59044.67% from -$4.0 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Change in Account Payables peaked at $10.6 million during Q4 2021, and registered a low of -$8.1 million during Q1 2025.
  • Over the past 5 years, Idexx Laboratories' median Change in Account Payables value was $1.4 million (recorded in 2021), while the average stood at $908000.0.
  • In the last 5 years, Idexx Laboratories' Change in Account Payables surged by 215927.51% in 2021 and then tumbled by 30110.95% in 2022.
  • Quarter analysis of 5 years shows Idexx Laboratories' Change in Account Payables stood at $10.6 million in 2021, then crashed by 30.19% to $7.4 million in 2022, then dropped by 15.61% to $6.2 million in 2023, then decreased by 8.06% to $5.7 million in 2024, then rose by 24.34% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q3 2025, -$4.0 million for Q2 2025, and -$8.1 million during Q1 2025.